Your browser doesn't support javascript.
loading
Coronary Artery Calcium for Risk Stratification Among Persons With Very High HDL Cholesterol.
Razavi, Alexander C; Mehta, Anurag; Wong, Nathan D; Rozanski, Alan; Budoff, Matthew J; Gianos, Eugenia; Vaccarino, Viola; van Assen, Marly; De Cecco, Carlo N; Miedema, Michael D; Rumberger, John A; Mortensen, Martin Bødtker; Shaw, Leslee J; Nasir, Khurram; Blumenthal, Roger S; Rohatgi, Anand; Quyyumi, Arshed A; Sperling, Laurence S; Whelton, Seamus P; Blaha, Michael J; Berman, Daniel S; Dzaye, Omar.
Afiliação
  • Razavi AC; Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Mehta A; Translational Laboratory for Cardiothoracic Imaging and Artificial Intelligence, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Wong ND; VCU Health Pauley Heart Center and Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
  • Rozanski A; Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California, Irvine, California, USA.
  • Budoff MJ; Division of Cardiology, Mount Sinai, St. Luke's Hospital, New York, New York, USA.
  • Gianos E; Lundquist Institute, Harbor-UCLA Medical Center, Torrance, California, USA.
  • Vaccarino V; Department of Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Hempstead, New York, USA.
  • van Assen M; Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
  • De Cecco CN; Translational Laboratory for Cardiothoracic Imaging and Artificial Intelligence, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Miedema MD; Translational Laboratory for Cardiothoracic Imaging and Artificial Intelligence, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Rumberger JA; Nolan Family Center for Cardiovascular Health, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
  • Mortensen MB; Corazon Imaging, Columbus, Ohio, USA.
  • Shaw LJ; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Nasir K; Blavatnik Family Women's Health Research Institute, Mount Sinai Medical Center, New York, New York, USA.
  • Blumenthal RS; Division of Cardiovascular Prevention and Wellness, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA.
  • Rohatgi A; Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Quyyumi AA; Division of Cardiology, Department of Medicine, University of Texas Southwestern School of Medicine, Dallas, USA.
  • Sperling LS; Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Whelton SP; Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Blaha MJ; Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Berman DS; Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dzaye O; Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California, United States.
JACC Adv ; 3(10): 101217, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39280798
ABSTRACT

Background:

Compared to normal high-density lipoprotein (HDL) cholesterol values, very high HDL cholesterol is associated with a higher incidence of mortality and atherosclerotic cardiovascular disease (ASCVD). As such, clinical risk stratification among persons with very high HDL cholesterol is challenging.

Objectives:

Among persons with very high HDL cholesterol, the purpose was to determine the prevalence of coronary artery calcium (CAC) and compare the association between traditional risk factors vs CAC for all-cause mortality and ASCVD.

Methods:

The primary analysis was completed among 446 participants from the Cedars-Sinai Medical Center of the CAC Consortium with very high HDL cholesterol (≥77 mg/dL in men, ≥97 mg/dL in women). Cox proportional hazards regression assessed the association of CAC and traditional risk factors with all-cause mortality during a median follow-up of 10.7 years. Replication and validation analyses were performed for all-cause mortality among 119 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with very high HDL cholesterol, who also had information on incident ASCVD.

Results:

The mean age was 57.9 years old, 49% were women, and the median HDL cholesterol was 98 mg/dL. One-half of participants (50%) had prevalent CAC, in whom the median CAC score was 118. Prevalent CAC conferred a 3.6-fold higher risk of all-cause mortality (HR 3.64; 95% CI 1.21-11.01), which appeared to be a more robust predictor than individual traditional risk factors beyond age. In the validation sample, prevalent CAC but not individual traditional risk factors were associated with all-cause mortality (HR 2.39; 95% CI 1.07-5.34) and a 4.0-fold higher risk of ASCVD (HR 4.06; 95% CI 1.11-14.84).

Conclusions:

Measurement of CAC may facilitate clinical risk assessment among individuals with very high HDL cholesterol.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JACC Adv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JACC Adv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos